Journal of Hematology & Thromboembolic Diseases

Journal of Hematology & Thromboembolic Diseases
Open Access

ISSN: 2329-8790

+44 1478 350008

Journal of Hematology & Thromboembolic Diseases : Citations & Metrics Report

Articles published in Journal of Hematology & Thromboembolic Diseases have been cited by esteemed scholars and scientists all around the world. Journal of Hematology & Thromboembolic Diseases has got h-index 16, which means every article in Journal of Hematology & Thromboembolic Diseases has got 16 average citations.

Following are the list of articles that have cited the articles published in Journal of Hematology & Thromboembolic Diseases.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Total published articles

40 65 62 50 23 6 15 27 26 56 70 25

Research, Review articles and Editorials

6 19 17 27 8 5 7 21 18 37 59 21

Research communications, Review communications, Editorial communications, Case reports and Commentary

28 46 39 23 14 1 5 6 8 14 24 4

Conference proceedings

0 6 35 35 0 0 41 25 33 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

82 96 141 153 144 131 107 118 119 66 40 4
Journal total citations count 1065
Journal impact factor 2.67
Journal 5 years impact factor 4.32
Journal cite score 4.94
Journal h-index 16
Journal h-index since 2019 12
Important citations (901)

Norton, a., pan, c., iskenderian, a., & strack-logue, b. (2020).

Rosado-quiñones, a. m., & zaragoza-urdaz, r. (2019). hereditary angioedema: an updated experience with patients with angioedema in puerto rico. puerto rico health sciences journal, 38(4).

Tarandovskiy, i., buehler, p., & karnaukhova, e. (2017). supra-physiological concentrations of c1 esterase inhibitor enhance thrombin generation in the presence of thrombomodulin.

Primary large b-cell mediastinal lymphoma: treatment

Relapsed/refractory primary mediastinal large b-cell lymphoma: a structured review of epidemiology, treatment guidelines and real-world treatment practices

Role of haemoglobin and their diseases

Role of haemoglobin and their diseases

Prodeus, a.p., ustinova, m.v., lekmanov, a.u., kudryashov, n.v., & kudlai, d.a. (2019). c1 esterase inhibitor: approaches to rational pharmacotherapy of neonatal sepsis. pediatriya named after gn speransky , 98 (3).

Tanaka, k. a., mondal, s., morita, y., williams, b., strauss, e. r., & cicardi, m. (2020). perioperative management of patients with hereditary angioedema with special considerations for cardiopulmonary bypass. anesthesia & analgesia, 131(1), 155-169.

Wong, c., muguiro, d. h., lavergne, s., behling-kelly, e., & goggs, r. (2018). pharmacokinetics of human recombinant c1-esterase inhibitor and development of anti-drug antibodies in healthy dogs. veterinary immunology and immunopathology, 203, 66-72.

Karnaukhova, e. (2021). c1-inhibitor: structure, functional diversity and therapeutic development. current medicinal chemistry.

A review on genetic disorders and syndromes

Prodeus, a.p., ustinova, m.v., korsunsky, a.a., & goncharov, a.g. (2018). new aspects of the pathogenesis of sepsis and septic shock in children. the complement system as a target for effective therapy. infection and immunity , 8 (1).

Role of haemoglobin and their diseases

Tarandovskiy, i. d., rajabi, a. a., karnaukhova, e., & buehler, p. w. (2019). contradictory to its effects on thrombin, c1-inhibitor reduces plasmin generation in the presence of thrombomodulin. journal of thrombosis and thrombolysis, 48(1), 81-87.

Tarandovskiy, i. d., buehler, p. w., ataullakhanov, f. i., & karnaukhova, e. (2019). c1-esterase inhibitor enhances thrombin generation and spatial fibrin clot propagation in the presence of thrombomodulin. thrombosis research, 176, 54-60.

Dijk, m., holkers, j., voskamp, p., giannetti, b. m., waterreus, w. j., van veen, h. a., & pannu, n. s. (2016). how dextran sulfate affects c1-inhibitor activity: a model for polysaccharide potentiation. structure, 24(12), 2182-2189.

Genetic biomarkers related to hemarthrosis, inflammation, and cartilage structure in pediatric patients with hemophilic arthropathy

Iborra-egea, o., rueda, f., garcía-garcía, c., borràs, e., sabidó, e., & bayes-genis, a. (2020). molecular signature of cardiogenic shock. european heart journal, 41(39), 3839-3848.

Riedl, m. (2015). recombinant human c1 esterase inhibitor in the management of hereditary angioedema. clinical drug investigation, 35(7), 407-417.

Top